MKRN1 Antibody Protocol: Applications & Usage Guide

MKRN1 Antibody is a research reagent targeting Makorin Ring Finger Protein 1 (MKRN1), an E3 ubiquitin ligase implicated in RNA biology, telomere regulation, and oncogenic signaling pathways.

Product Name

MKRN1 Antibody

Catalog Number

Ab351306

Formulation

PBS Only (no carrier protein, no azide)

Target Protein

MKRN1 (Makorin Ring Finger Protein 1)

Protein Function

E3 ubiquitin ligase; roles in RNA regulation, telomere biology, and p53 pathway

Storage Recommendation

Store at –20 °C; avoid repeated freeze–thaw cycles

Materials Required

Before beginning the protocol, ensure the following materials are available:

• MKRN1 Antibody (Ab351306) – formulated in PBS only; no carrier protein or preservative.
• Appropriate secondary antibody conjugated to HRP, fluorophore, or other detection moiety.
• Blocking buffer (e.g., 5% non-fat dry milk or 5% BSA in TBST, depending on application).
• Cell or tissue lysates, fixed cells, or FFPE tissue sections as appropriate for the chosen application.
• Standard SDS-PAGE or immunofluorescence equipment.
• PVDF or nitrocellulose membrane (for Western blot).
• Wash buffer: TBS-T (50 mM Tris, 150 mM NaCl, 0.1% Tween-20, pH 7.4).

Note: Because the antibody is formulated in PBS without carrier protein, it is compatible with direct conjugation chemistry if conjugation is required for specialized assays.

Sample Preparation

Proper sample preparation is critical for consistent detection of MKRN1.

Cell Lysate Preparation (Western Blot)

1. Aspirate culture medium and wash cells twice with ice-cold PBS.
2. Lyse cells in RIPA buffer supplemented with protease inhibitor cocktail and phosphatase inhibitors on ice for 20–30 minutes.
3. Centrifuge at 12,000 × g for 15 minutes at 4 °C; collect the supernatant.
4. Quantify protein concentration using a BCA or Bradford assay.
5. Prepare samples in SDS loading buffer; denature at 95 °C for 5 minutes.

Tissue Section Preparation (IHC/IF)

1. For FFPE sections, perform standard deparaffinization and rehydration.
2. Perform antigen retrieval using citrate buffer (pH 6.0) or EDTA buffer (pH 9.0) as appropriate.
3. Block endogenous peroxidase activity if using HRP-based detection.

Optimal lysis conditions and antigen retrieval methods should be validated empirically for each cell or tissue type.

Antibody Incubation & Detection

The following steps outline the recommended incubation procedure. Optimal working dilutions must be determined empirically by the end user, as the source material does not specify validated dilution ranges for Ab351306.

Primary Antibody Incubation

1. Block membrane or tissue sections with appropriate blocking buffer for 1 hour at room temperature.
2. Dilute MKRN1 Antibody (Ab351306) in blocking buffer at the empirically determined working concentration.
3. Incubate with primary antibody overnight at 4 °C with gentle agitation.
4. Wash three times with TBS-T, 10 minutes per wash.

Secondary Antibody & Detection

1. Incubate with appropriate HRP- or fluorophore-conjugated secondary antibody for 1 hour at room temperature.
2. Wash three times with TBS-T, 10 minutes per wash.
3. For Western blot: apply ECL substrate and capture signal by chemiluminescence imager or X-ray film.
4. For IF/IHC: apply appropriate chromogenic or fluorescent substrate and counterstain as required.

Because Ab351306 is formulated in PBS without preservative, handle aseptically and store aliquots at –20 °C to maintain activity.

Troubleshooting

If unexpected results are obtained, consult the troubleshooting guidance below:

Problem	Possible Cause	Suggested Action
No signal	Antibody concentration too low; antigen not expressed in sample	Increase primary antibody concentration; confirm MKRN1 expression in cell/tissue type; use positive control lysate
High background	Insufficient blocking; antibody concentration too high; inadequate washing	Extend blocking time; reduce antibody concentration; increase number or duration of washes
Non-specific bands (WB)	Cross-reactivity; sample degradation	Confirm fresh protease inhibitors used; optimize dilution; verify sample integrity
Weak signal (IHC/IF)	Suboptimal antigen retrieval	Optimize antigen retrieval method (pH 6.0 vs pH 9.0); extend retrieval time

Always include a negative control (primary antibody omitted) and, where possible, a positive control with confirmed MKRN1 expression.

Frequently asked questions

What applications is MKRN1 Antibody (Ab351306) validated for?

The source material does not specify validated applications for Ab351306. Users should empirically validate the antibody for their intended application, such as Western blot, immunohistochemistry, or immunofluorescence, and include appropriate positive and negative controls.

Why is MKRN1 Antibody formulated in PBS only, without carrier protein?

A carrier-protein-free, preservative-free PBS formulation is preferred when the antibody will be directly conjugated to labels, enzymes, or solid supports, as carrier proteins and azide can interfere with conjugation chemistry. This formulation also avoids azide toxicity concerns in certain assay formats.

How should MKRN1 Antibody (Ab351306) be stored to maintain activity?

Store the antibody at –20 °C in single-use aliquots to avoid repeated freeze–thaw cycles, which can reduce antibody activity. Because the formulation contains no preservative such as sodium azide, maintain aseptic handling conditions to prevent microbial contamination.

What is MKRN1 and why is it a relevant research target?

MKRN1 (Makorin Ring Finger Protein 1) is a RING-domain E3 ubiquitin ligase involved in protein ubiquitination and degradation. It has been linked to regulation of p53, telomere biology, and RNA-binding functions, making it relevant to cancer biology, aging research, and gene expression studies.

What positive control can I use when working with MKRN1 Antibody?

Cell lines with known MKRN1 expression, such as HeLa or HEK293, are commonly used as positive controls in Western blot experiments targeting ubiquitin pathway proteins; however, users should verify MKRN1 expression levels in their chosen cell line prior to use, as expression can vary.

References

1. Hilker M et al. Makorin Ring Finger Protein 1 (MKRN1): structural and functional overview. [Review – general reference; specific citation to be confirmed]
2. Ko A et al. Oncogenic role of MKRN1 as an E3 ubiquitin ligase targeting tumor suppressors. [Specific citation to be confirmed]
3. Absea Biotechnology. OC-2507 MKRN1 Antibody product datasheet. Aladdin Scientific catalog Ab351306.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.